Kirk S. Culotta
- Immunology top 5%
- Oncology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Cancer Research
- Co-authors
- Augusto C. OchoaArnold H. ZeaJovanny ZabaletaPaulo C. Rodrı́guezJuan B. OchoaJoanna DeSalvoDavid QuicenoAdel K. El‐Naggar
- Topics
- Cancer Treatment and Pharmacology (7 papers)Immune Cell Function and Interaction (4 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)
- Partner nations
- United StatesCanadaTaiwan
In The Last Decade
Kirk S. Culotta
24 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 94
- Immunology 732
- Oncology 396
- Molecular Biology 394
- Pulmonary and Respiratory Medicine 186
- Cancer Research 133
Countries citing papers authored by Kirk S. Culotta
This map shows the geographic impact of Kirk S. Culotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk S. Culotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk S. Culotta more than expected).
Fields of papers citing papers by Kirk S. Culotta
This network shows the impact of papers produced by Kirk S. Culotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk S. Culotta. The network helps show where Kirk S. Culotta may publish in the future.
Co-authorship network of co-authors of Kirk S. Culotta
This figure shows the co-authorship network connecting the top 25 collaborators of Kirk S. Culotta. A scholar is included among the top collaborators of Kirk S. Culotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk S. Culotta. Kirk S. Culotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | 30 | |
| 3 | 14 | |
| 4 | 6 | |
| 5 | 25 | |
| 6 | 1 | |
| 7 | 21 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | 39 | |
| 11 | 27 | |
| 12 | 84 | |
| 13 | 1 | |
| 14 | 182 | |
| 15 | 6 | |
| 16 | The preclinical pharmacology of WP1066, a potent small molecule inhibitor of the JAK2/STAT3 pathway | 10 |
| 17 | 57 | |
| 18 | 175 | |
| 19 | 393 | |
| 20 | 397 |
About Kirk S. Culotta
Kirk S. Culotta is a scholar working on Oncology, Hematology and Hepatology, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Immune Cell Function and Interaction (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Immunology (732 citations), Biological Psychiatry (41 citations) and Applied Microbiology and Biotechnology (31 citations). Kirk S. Culotta has collaborated with scholars based in United States, Canada and Taiwan. Frequent co-authors include Augusto C. Ochoa, Arnold H. Zea, Jovanny Zabaleta, Paulo C. Rodrı́guez, Juan B. Ochoa, Joanna DeSalvo, David Quiceno, Adel K. El‐Naggar, Vassiliki A. Papadimitrakopoulou and Claudia Patricia Pardo Hernández. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.